Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 1,701–1,800 of 2,099
Malnutrition management of hospitalized patients with diabetes/hyperglycemia and sarcopenia
Almeida, J. M. G., López, M. L., Burgos, R., Matía-Martín, P., Milla, S. P., París, A. S., Murillo, A. Z., Martínez, J. J. A., Fullana, A. A., Chinchetru, M. A. J., et al. (2022) · Nutrición Hospitalaria · doi:10.20960/nh.04507 · Cited by 4
Chaudhari, U. K., & HANSEN, B. C. (2023) · Journal of Medical Primatology · doi:10.1111/jmp.12633 · Cited by 1
Azócar-Gallardo, J., Ojeda-Aravena, A., Martín, E. B.-S., Campos-Uribe, V., González-Rojas, L., Cerda, M. A. C., & García‐García, J. M. (2023) · Applied Sciences · doi:10.3390/app13042238 · Cited by 1
Organ-on-chip-based disease models
Fernández‐Costa, J. M., Chiara, F. D., & Ramón‐Azcón, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15384-6.00005-7 · Cited by 1
Obesity: A Multi Perspective of Physiology and Neurobiology Energy Regulation
Meiliana, A., Dewi, N. M., & Wijaya, A. (2024) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v16i1.2840 · Cited by 2
“(44,45) When there is no corresponding rise in insulin release from the pancreatic beta cells, the quantity of glucose entering the muscle cells and adipocytes from the bloodstream is decreased, together with a lessened suppression of hepatic glucose production would raise blood glucose levels.”
BackgroundJalo, A., Helin, J. S., Hentilä, J., Nissinen, T. A., Honkala, S. M., Heiskanen, M. A., Löyttyniemi, E., Malm, T., & Hannukainen, J. C. (2024) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk9020058 · Cited by 4
“…even short-term fat-feeding protocols in rodents can produce marked hepatic lipid accumulation and hepatic insulin resistance without noticeable skeletal muscle insulin resistance [38,39], while skeletal muscle insulin resistance is thought to precede hepatic insulin resistance in humans [40,41].”
BackgroundDrug Delivery Systems for Muscles
Naito, M., & Hori, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-55653-1_6 · Cited by 3
Devakrishna, K., Taj, G., & Upadhyay, S. (2024) · Annals of Phytomedicine An International Journal · doi:10.54085/ap.2024.13.1.60 · Cited by 2
“Skeletal muscle is the main location of insulin-mediated glucose absorption in humans during the postprandial state (DeFronzo and Tripathy, 2009).”
Genetically proxied appendicular lean mass and stroke risk: A two-step mendelian randomization study
Li, Z., Liu, X., Wen, J., Wang, Z., Xie, Y., Zhu, L., Wu, X., Fang, C., Tian, Y., & Li, Q. (2024) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2024.107915 · Cited by 1
Wu, D., Shi, S., Li, K., & Zhong, V. W. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae541
Lin, S., Dong, L., Nardo, W. D., Leeming, M. G., Cheng, Z., Williamson, N. A., Watt, M. J., & Montgomery, M. K. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00359.2024 · Cited by 1
Rana, K. S., Marwah, M. K., Raja, F. N. S., Dias, I. H. K., Hindalekar, Y. S., Tahan, M. A. A., Brown, J. E. P., & Bellary, S. (2025) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2025.2475441 · Cited by 1
“…not been investigated. b -cell failure is critical in the manifestation of T2D, however, it remains secondary to skeletal muscle insulin resistance which is believed to be the primary defect in the development of T2D and clinically evident before b -cell failure and overt hyperglycemia ensue [16].”
Food choices and body weight changes: A mathematical model analysis
Chudtong, M., & Gaetano, A. D. (2025) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2025065 · Cited by 2
The muscle specific MEF2Dα2 isoform promotes muscle ketolysis and running capacity in mice
Kumar, S., Ji, X., Iqbal, H., Guan, X., Mis, B., Dave, D. D., Kumar, S. N., Besler, J., Dash, R. K., Xia, Z., et al. (2025) · EMBO Reports · doi:10.1038/s44319-025-00578-3 · Cited by 1
“There is a growing recognition of the role skeletal muscle plays in whole-body metabolism as early disruptions in skeletal muscle carbohydrate and fatty acid metabolism correlate with developing type II diabetes and obesity (DeFronzo and Tripathy, 2009; Holloway et al, 2009; Kim et al, 2000).”
Linking Inflammation, Obesity, and Diabetes
McArdle, M. A., Kennedy, E. B., & Roche, H. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-40116-9_29 · Cited by 1
Green Tea Polyphenols: a Natural Therapeutic Approach for Metabolic Syndrome and Diabetes Prevention
Jung, J., & Kim, Y. A. (2014) · Cited by 1
Nutritional profile of patients with type 2 Diabetes Mellitus in Ribeirão Preto family health units
Baldoni, N. R., & Fabbro, A. L. D. (2018) · Ciência & Saúde · doi:10.15448/1983-652x.2018.2.26030 · Cited by 1
HO-1-derived CO Is a Regulator of Vascular Function and Metabolic Syndrome
Schragenheim, J., Maayan, O., & Abraham, N. G. (2018) · Royal Society of Chemistry eBooks · doi:10.1039/9781788013000-00059 · Cited by 1
Chattu, M. (2016) · Research in Pharmacy and Health Sciences · doi:10.32463/rphs.2016.v02i02.15 · Cited by 1
“The Diabetogenic effect of exogenous or endogenous Glucocorticoid excess results in part from the development of peripheral insulin resistance [1], a wherein insulin fails to normally stimulate glucose uptake into skeletal muscle, the main site of insulin-mediated glucose disposal [2].”
BackgroundEgan, B. M. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-75310-2_35 · Cited by 1
Methylglyoxal impairs β-adrenergic signalling in primary rat adipocytes
Szkudelski, T., Cieślewicz, A., & Szkudelska, K. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1684953 · Cited by 1
“…Department of Animal Physiology and Biochemistry, Poznan University of Life Sciences, Wolynska 35, Poznan 60-637, Poland 2019 Informa UK Limited, trading as Taylor & Francis Group of circulating glucose and have an important role in glucose homeostasis (DeFronzo and Tripathy 2009).”
BackgroundInfluentialKim, J. (2021) · The Asian Journal of Kinesiology · doi:10.15758/ajk.2021.23.3.38 · Cited by 1
Lundström, P., Lauruschkus, K., Andersson, Å., & Tornberg, Å. B. (2022) · Pediatric Exercise Science · doi:10.1123/pes.2021-0098 · Cited by 3
“Glucose uptake in skeletal muscle requires a normal viable muscle (12), but in some conditions, as in children and adolescents with cerebral palsy (CP), there may be an ongoing dynamic process of muscle hypertrophy and atrophy from birth, contributing to impaired glucose uptake (29).”
BackgroundRahmi, R., Machrina, Y., & Yamamoto, Z. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.7913 · Cited by 4
“T2DM is characterized by insulin resistance, a condition in which cells are unable to respond to insulin, especially in the liver, skeletal muscle, and fat tissue [34].”
BackgroundGrundy, S. M. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_3-2 · Cited by 2
Oghagbon, E. K. (2018) · Journal of BioMedical Research and Clinical Practice · doi:10.46912/jbrcp.55 · Cited by 1
de Campos, M. L., Fernandes, M. F., de Castro, M. B., Campos, A. D., Pires, P. P., Andrade, R. D. O., de Oliveira, I. M., Silva, A. M., Sabarense, C. M., Castañon, M. C. M. N., et al. (2022) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2022.102376 · Cited by 1
Pillai, J. S., Nair, P., Nandakumar, S., Thomson, R. J., & Pillai, S. S. (2023) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2023.150302
Glucose and lipid metabolism in human skeletal muscle
Skrobuk, P. (2012) · Helda - University of Helsinki Institutional Repository · Cited by 4
Nutrition, Physical Activity, and Health
Braun, B., & Miller, B. F. (2013) · Wiley eBooks · doi:10.1002/9781118692318.ch37 · Cited by 1
Polycystic Ovary Syndrome, Obesity and Insulin Resistance
Cassar, S. (2014) · Victoria University Research Repository (Victoria University) · Cited by 1
(2009) · Chemical industries · doi:10.1201/9781420059656-p8 · Cited by 1
Insulin Signaling, Epigenetics, and Human Diseases
Chruvattil, R., Belani, M., Patel, T. P., & Gupta, S. S. (2017) · Wiley eBooks · doi:10.1002/9783527697274.ch18 · Cited by 1
Raizel, R. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2017.tde-26102017-112453 · Cited by 1
Dunford, E. C. (2016) · YorkSpace (York University) · Cited by 1
Ferreira, R. S. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2018.tde-17102018-104638 · Cited by 4
From Cellular Mechanisms to Physiological Responses
Newman, R. H. (2019) · Wiley eBooks · doi:10.1002/9781119060208.ch3 · Cited by 1
Ferrara, P. J., Rong, X., Maschek, J. A., Verkerke, A. R. P., Siripoksup, P., Song, H., Krishnan, K. C., Johnson, J. M., TURK, J. W., Houmard, J. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.23.887232 · Cited by 1
“Insulin resistance in skeletal muscle is a 57 necessary precursor to type 2 diabetes (5) and can be triggered by aberrant lipid metabolism (658 8).”
BackgroundAli, M. S., Bitsch-Olsen, S., Frank, E., Battey, E., Perla, M., Themsen, S. S. B., Raun, S. H., de Jong, S., & Sylow, L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.27.921262 · Cited by 1
Biswas, D., Dao, K. T., Mercer, A., Cowie, A. M., Duffley, L., Hiani, Y. E., Kienesberger, P. C., & Pulinilkunnil, T. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.21.960153 · Cited by 1
“Skeletal and cardiac muscle insulin signaling and sensitivity are critical for metabolic homeostasis and organ function (23,24).”
BackgroundSystemic benefits of Gc inhibition to preserve insulin sensitivityPreprint
Kuo, T., & Accili, D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.06.328963 · Cited by 1
“12 Skeletal muscle is the major site of insulin-stimulated glucose uptake in humans (22).”
BackgroundThe Effects of BPA and BPS on Skeletal Muscle and Adipose Tissue Metabolism
Ahmed, F. (2020) · uO Research (University of Ottawa) · doi:10.20381/ruor-25234 · Cited by 1
“The skeletal muscle accounts for a majority of glucose disposal within the body, therefore, is crucial in regulating whole-body glucose metabolism (DeFronzo and Tripathy, 2009).”
BackgroundInfluentialWisinski, J. A., Reuter, A., Peter, D. C., Schaid, M. D., Fenske, R. J., & Kimple, M. E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/671289 · Cited by 1
“While skeletal muscle insulin resistance has been identified as the primary defect in these populations, the progression to T2D is dependent on the beta-cell [25-29].”
BackgroundProlonged exposure to insulin causes epigenetic alteration leading to insulin resistancePreprint
Bano, S., More, S., Mongad, D., Khalique, A., Dhotre, D. P., Bhat, M. K., & Seshadri, V. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.28.489884 · Cited by 1
Kempermann, G. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733851922.793550051 · Cited by 1
Oh, H., Cho, W., El‐Aty, A. M. A., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4149178 · Cited by 1
López‐Soldado, I., Torres, A. G., Ventura, R., Martínez-Ruíz, I., Díaz‐Ramos, A., Planet, E., Cooper, D., Pazderska, A., Wanic, K., O’Hanlon, D., et al. (2022) · medRxiv · doi:10.1101/2022.12.30.22283970 · Cited by 1
Impact of Zinc on Insulin Resistance and Hepatic Fat AccumulationPreprint
Fatehi, M. (2023) · Preprints.org · doi:10.20944/preprints202301.0012.v1 · Cited by 1
Aminov, E., Folan, P., & Pisconti, A. (2024) · bioRxiv · doi:10.1101/2024.06.29.601052 · Cited by 2
Lee, J.-H., Jung, I., Tu‐Sekine, B., Jin, S., Anokye‐Danso, F., Ahima, R. S., & Kim, S. F. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.28.605526 · Cited by 1
Waterman, H. L., Moore, M. C., Smith, M. S., Farmer, B., Yankey, K. C., Scott, M. F., Edgerton, D. S., & Cherrington, A. D. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.25.614969 · Cited by 1
Robben, S., Davidson, P., Ribeiro, R. S. R., & Voets, T. (2026) · eLife · doi:10.1101/2025.05.25.655695 · Cited by 1
“These experiments revealed that ISN partly reversed effects of PS on calcium oscillations and insulin release, indicating that the positive effects of PS on insulin release are at least partly mediated by TRPM3.”
Tribbles 3 blunts exercise-induced skeletal muscle adaptationPreprint
Choi, R. H., McConahay, A., Johnson, M. B., Ojemuyiwa, M., Phillips, B. J., Jeong, H.-W., & Koh, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.16.665065 · Cited by 1
Zhong, H., Ma, S., Lillback, V., Gao, M., Zhang, W., Johari, M., Oghabian, A., Jonson, P. H., Xi, J., Zhu, W., et al. (2026) · medRxiv · doi:10.64898/2026.05.11.26352204 · Cited by 1
CL316,243 and skeletal muscle metabolism: Role of sex and estrogen receptor beta
Maloney, A., Lee, J., Queathem, E. D., Schaller, K. A., Buckhary, S., Lubahn, D. B., Valentine, R. J., & Vieira-Potter, V. J. (2025) · Journal of Endocrinology · doi:10.1530/joe-25-0005 · Cited by 1
In vivo and in vitro regulation of skeletal muscle lipid metabolism
Gabriel, B. M. (2014)
TGF-β and Metabolic Homeostasis
Bennett, G., & Rane, S. G. (2013) · Springer eBooks · doi:10.1007/978-4-431-54409-8_18
Role of immune mediators in metabolic syndrome and atherosclerosis
Strodthoff, D. (2013) · Figshare
Mellberg, C. (2014) · DiVA at Umeå University (Umeå University)
Nutritional modulation of hepatic lipid metabolism in health and disease
Johnston, R. D. (2012) · Nottingham ePrints (University of Nottingham)
Caracterização fenotípica de camundongos knockout para neurolisina.
Cavalcanti, D. M. L. D. P. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2014.tde-13082014-140429
Naowaboot, J., Somparn, N., Saentaweesuk, S., et al. (2014) · Asian Medical Journal and Alternative Medicine · doi:10.70933/2773-9465.1585
Molecular regulators of glucose and lipid metabolism in skeletal muscle
Kulkarni, S. S. (2012) · Figshare
Venskutonytė, L. (2013) · Figshare
Exercise capacity with special reference to type 2 diabetes
Tornberg, Å. B. (2010) · Lund University Publications (Lund University) · Cited by 1
Methodological studies applying new techniques for evaluation of arterial function
Ring, M. (2014) · Figshare
Metcalfe, R. S. (2015) · The University of Bath Online Publications Store (The University of Bath) · doi:10.13140/rg.2.1.4944.0088
Deleskog, A. (2013) · Figshare
Studies on factors modulating glucose homeostasis in healthy and diabetic rats
Yassin, K. (2011) · Figshare
Clarke, K. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
Central and peripheral mechanisms regulating energy and glucose homeostasis
Tom, R. Z. (2013) · Figshare
The Effect of Myostatin on Glucose Metabolism and Insulin Sensitivity
Ghozlan, M. (2013) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/28087
Apical Periodontitis, inflammation and insulin resistance
(2015) · Inflammation and Cell Signaling · doi:10.14800/ics.1055 · Cited by 1
Molecular and physiological regulation of adiponectin exocytosis in white adipocytes
Komai, A. M. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Relative contribution of β-cell dysfunction to glucose homeostasis impairment.
Ivanova, Z., & Georgiev, I. P. (2013) · Bulgarian Portal for Open Science
Ko, G. (2013) · QSpace (Queen's University Library)
Viitasalo, A. (2015) · UEF eRepo (University of Eastern Finland) · Cited by 2
Harfmann, B. D. (2015) · UKnowledge (University of Kentucky)
Viscarra, J. A. (2013) · eScholarship (California Digital Library)
Ivanova, Z., Penchev, G., Ribarski, S., Vachkova, Е., Григорова, Н., Roussenov, A., Yonkova, P., Kostov, D., Georgieva, T. M., Milanova, A., et al. (2015) · BULGARIAN JOURNAL OF VETERINARY MEDICINE · doi:10.15547/bjvm.886
“Obesity-induced fasting hyperinsulinaemia has been also described in cats (Thiess et al., 2004; Appleton et al., 2005), dogs (Verkest et al., 2005; Verkest et al., 2011) and humans (Festa et al., 2008; DeFronzo & Tripathy, 2009; Gil-Campos et al., 2010).”
BackgroundCoelho, J. M. C. Í. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Damacharla, D. (2015) · Human Biology
Actividad física laboral y composición corporal en mujeres adultas.
Rodríguez‐Rodríguez, F., Fuentes, M., & Cristi‐Montero, C. (2013) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata)
Matravadia, S. (2016) · The Atrium (University of Guelph)
Regulation of adipogenesis and inflammation: role(s) of adipose microRNAs
Al-Jabir, M. J. M. H. (2016) · UCL Discovery (University College London)
Optimal Carbohydrate and Nutrient Intake for Japanese Elderly Patients with Type 2 Diabetes
Kamada, C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-800093-9.00025-9
Cell-Type Specific GRK2 Interactomes: Pathophysiological Implications
Mayor, F., Vila‐Bedmar, R., Nogués, L., Cruces‐Sande, M., Lucas, E., Rivas, V., Reglero, C., Penela, P., & Murga, C. (2016) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3798-1_6 · Cited by 2
Cellular Effects of Insulin in Human THP-1 Monocytes
Naderi, J. (2015) · NVA (Nasjonalt vitenarkiv)
The influence of age and nutrients on insulin sensitivity
Chee, C. (2016) · Nottingham ePrints (University of Nottingham) · Cited by 2
Amino Acids Supplementation as Nutritional Therapy Strategy in Diabetes Mellitus
D’Antona, G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-800093-9.00032-6 · Cited by 2
Avaliação da sensibilidade à insulina em pacientes com lúpus eritematoso sistêmico
Miyake, C. N. H. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2016.tde-08092016-100644
Paracrine regulation of glucagon secretion from pancreatic islets
Elliott, A. D. (2014)
Rached, M.-T. (2014) · Spiral (Imperial College London) · doi:10.25560/38448
Proatherogenic crosstalk between adipose tissue and smooth muscle cells
Schlich, R. (2012)
Huber, G., & Köppel, M. (2016) · B&G Bewegungstherapie und Gesundheitssport · doi:10.1055/s-0042-119081
Role of the carotid body in metabolic disturbances
Ribeiro, M. J. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.